Radiolabeled Somatostatin Analogs-A Continuously Evolving Class of Radiopharmaceuticals.

Cancers (Basel) · 2022 · PMC8909681 · PMID 35267479

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

36.3 (95% CI, 25.9–51.7) months, respectively), which, however, did not reach statistical significance in the long-term follow-up with a median of 6.3 years [ 24 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.